Skip to main content

Table 2 Dissociation constants (K d), apparent number of binding sites per cells (B max), and serum half-life of DOTA-PEG4-BN conjugates

From: Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors

Peptide conjugates

K d/nM

B max (binding sites/cell) *105

Half-life/h

BN1

3.30 ± 0.90

2.45 ± 0.73

16.1

BN2

4.27 ± 1.28

4.10 ± 1.23

20.9

BN3

>1000

ND

40.7

BN4

4.97 ± 1.40

5.54 ± 1.56

224.1

BN5

10.89 ± 2.71

1.56 ± 0.39

354.2

BN6

3.90 ± 1.15

5.89 ± 1.74

208.3

BN7

6.36 ± 1.74

5.32 ± 1.46

18.7

BN8

5.91 ± 1.77

3.52 ± 1.03

414.1

  1. ND not determinable